Narkus, A.
Allergopharma GmbH & Co. KG (Germany)
2 papers on CoChat
Most cited papers
- Verified
Double‐blind, placebo‐controlled, dose‐ranging study of new recombinant hypoallergenic Bet v 1 in an environmental exposure chamber
Meyer, W., Narkus, A., Salapatek, A. M., & Häfner, D. (2013) · Allergy
Allergic Rhinitis and SensitizationFood Allergy and Anaphylaxis Research
Cited by 72
- Verified
Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1‐FV in a randomized controlled trial
Klimek, L., Bachert, C., Lukat, K., Pfaar, O., Meyer, H., & Narkus, A. (2015) · Clinical and Translational Allergy
Allergic Rhinitis and SensitizationFood Allergy and Anaphylaxis Research
Cited by 54
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free